XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q1)Dec 29, 2024 | (FY)Sep 29, 2024 | (Q4)Sep 29, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Oct 1, 2023 | (Q4)Oct 1, 2023 | (Q3)Jul 2, 2023 | (Q2)Apr 2, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -13.08%2.07B | 1.45%6.1B | -21.05%1.54B | -1.93%1.67B | -34.08%506M | 2.38B | 36.65%6.01B | 76.87%1.95B | 34.64%1.7B | 767.6M |
Net income from continuing operations | -23.77%780.9M | -8.79%3.76B | -25.40%909.6M | -7.53%1.06B | -14.96%772.5M | --1.02B | 25.62%4.12B | 38.78%1.22B | 24.96%1.14B | --908.4M |
Operating gains losses | 60.26%-12.2M | 36.61%-184.9M | 52.17%-46.3M | 29.58%-48.8M | 34.19%-59.1M | ---30.7M | -64.52%-291.7M | -5.33%-96.8M | -57.50%-69.3M | ---89.8M |
Depreciation and amortization | 12.43%432.2M | 9.80%1.59B | 6.61%401.4M | 11.77%407.4M | 8.83%399.2M | --384.4M | -5.17%1.45B | 4.47%376.5M | -6.85%364.5M | --366.8M |
Deferred tax | -157.09%-14.9M | 76.77%-13.8M | -4.11%-30.4M | 138.41%12.6M | -67.42%-22.1M | --26.1M | -57.14%-59.4M | 59.89%-29.2M | -596.97%-32.8M | ---13.2M |
Other non cash items | 64.54%486.7M | -3.30%1.35B | -34.32%244M | -4.08%397M | 21.70%410M | --295.8M | -2.60%1.39B | -3.31%371.5M | 5.34%413.9M | --336.9M |
Change In working capital | -55.20%216.8M | 7.46%-1.05B | -172.38%-127.2M | -16.67%-283.5M | -30.78%-1.12B | --483.9M | 46.86%-1.13B | 90.83%-46.7M | 51.22%-243M | ---857.9M |
-Change in receivables | -279.20%-75.8M | 548.78%18.4M | 45.66%-26.3M | -330.39%-41.7M | 379.11%44.1M | --42.3M | 98.74%-4.1M | 39.95%-48.4M | 109.87%18.1M | ---15.8M |
-Change in inventory | -85.60%25.1M | -88.32%42.8M | -44.04%96.2M | -117,800.00%-117.9M | -227.53%-109.8M | --174.3M | 157.16%366.4M | 305.38%171.9M | 99.96%-100K | --86.1M |
-Change in payables and accrued expense | 257.25%335.1M | -122.21%-33.9M | -178.36%-44.9M | 12.85%147.5M | -250.53%-230.3M | --93.8M | -22.10%152.6M | 139.30%57.3M | -37.37%130.7M | ---65.7M |
-Change in other current liabilities | -75.63%-510.2M | 10.31%-1.29B | 36.76%-245.2M | 4.54%-414.6M | -1.23%-344.6M | ---290.5M | 11.18%-1.44B | 8.60%-387.7M | 0.18%-434.3M | ---340.4M |
-Change in other working capital | -4.61%442.6M | 206.99%218.8M | -41.95%93M | 236.15%143.2M | 7.80%-481.4M | --464M | -177.52%-204.5M | -28.89%160.2M | -70.42%42.6M | ---522.1M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -13.08%2.07B | 1.45%6.1B | -21.05%1.54B | -1.93%1.67B | -34.08%506M | --2.38B | 36.65%6.01B | 76.87%1.95B | 34.64%1.7B | --767.6M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -50.35%-855.2M | -18.87%-2.7B | 1.72%-849.7M | -17.29%-585.5M | -10.75%-695.2M | -568.8M | -5.80%-2.27B | -12.29%-864.6M | -0.77%-499.2M | -627.7M |
Net PPE purchase and sale | -16.28%-692.9M | -19.02%-2.78B | -14.11%-798.2M | -14.59%-724.3M | -35.84%-659.1M | ---595.9M | -26.74%-2.33B | -28.14%-699.5M | -49.26%-632.1M | ---485.2M |
Net business purchase and sale | ---177.1M | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net investment purchase and sale | -41.48%21.3M | 1,596.63%151M | 76.36%-35.7M | 17.54%159.5M | 95.81%-9.2M | --36.4M | 103.74%8.9M | 40.27%-151M | 395.00%135.7M | ---219.4M |
Net other investing changes | 30.11%-6.5M | -234.88%-72.7M | -12.06%-15.8M | -639.29%-20.7M | -134.98%-26.9M | ---9.3M | 142.68%53.9M | 53.92%-14.1M | 89.19%-2.8M | --76.9M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -50.35%-855.2M | -18.87%-2.7B | 1.72%-849.7M | -17.29%-585.5M | -10.75%-695.2M | ---568.8M | -5.80%-2.27B | -12.29%-864.6M | -0.77%-499.2M | ---627.7M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 68.67%-754.8M | -24.33%-3.72B | 26.57%-644.5M | 21.63%-650.1M | 94.81%-14.3M | -2.41B | 46.96%-2.99B | -55.40%-877.7M | 39.20%-829.5M | -275.6M |
Net issuance payments of debt | 98.76%-5.4M | -61.94%136.5M | -1,983.33%-25M | -35.44%-21.4M | 12.17%617.6M | ---434.7M | -46.72%358.6M | 95.20%-1.2M | 98.04%-15.8M | --550.6M |
Net common stock issuance | 101.39%17.1M | -41.82%-1.16B | 110.78%28.8M | 110.38%20.8M | 112.79%26.1M | ---1.23B | 79.11%-817M | -1,123.37%-267.1M | -5,516.22%-200.4M | ---204M |
Cash dividends paid | -6.76%-691.9M | -6.30%-2.59B | -6.43%-646M | -6.27%-645.5M | -5.96%-645.4M | ---648.1M | -7.44%-2.43B | -7.97%-607M | -8.10%-607.4M | ---609.1M |
Net other financing activities | 19.00%-74.6M | -10.56%-111M | 4.17%-2.3M | 32.20%-4M | 3.82%-12.6M | ---92.1M | 26.39%-100.4M | 35.14%-2.4M | -321.43%-5.9M | ---13.1M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 68.67%-754.8M | -24.33%-3.72B | 26.57%-644.5M | 21.63%-650.1M | 94.81%-14.3M | ---2.41B | 46.96%-2.99B | -55.40%-877.7M | 39.20%-829.5M | ---275.6M |
Net cash flow | ||||||||||
Beginning cash position | -7.47%3.29B | 26.01%3.55B | -5.30%3.18B | -10.02%2.76B | -5.84%3B | --3.55B | -56.34%2.82B | 5.65%3.36B | -21.51%3.07B | --3.19B |
Current changes in cash | 177.75%462M | -143.06%-321.8M | -79.58%41.4M | 16.14%434.6M | -50.04%-203.6M | ---594.2M | 122.06%747.3M | 186.22%202.7M | 162.89%374.2M | ---135.7M |
Effect of exchange rate changes | -278.19%-76.8M | 497.89%56.5M | 901.22%65.7M | 77.98%-19.6M | -255.71%-32.7M | --43.1M | 94.33%-14.2M | 93.39%-8.2M | 36.83%-89M | --21M |
End cash Position | 22.36%3.67B | -7.47%3.29B | -7.47%3.29B | -5.30%3.18B | -10.02%2.76B | --3B | 26.01%3.55B | 26.01%3.55B | 5.65%3.36B | --3.07B |
Free cash flow | -22.87%1.38B | -9.71%3.32B | -40.79%737.4M | -11.67%945.8M | -154.21%-153.1M | --1.79B | 43.78%3.68B | 124.90%1.25B | 27.28%1.07B | --282.4M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |